UK fillip for Bracco as NICE voices resounding support for SonoVue
This article was originally published in Clinica
Bracco Diagnostics’ SonoVue imaging agent has been thrust into mainstream UK liver care protocols after the National Institute for Heath and Clinical Excellence (NICE) issued a resoundingly positive appraisal of the ultrasound-enhancing technology’s capacity to diagnose and investigate primary and secondary cancers and cirrhosis.
You may also be interested in...
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.
Netherlands' Authority for Consumers and Markets has reprimanded a dietary supplements player for purchasing fake followers and likes on social media to exaggerate the popularity of its products. It is the first case of its kind in the country.